嘉事堂(002462) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 reached ¥3,788,463,600.14, representing a 25.00% increase compared to ¥3,030,784,781.70 in the same period last year[8] - Net profit attributable to shareholders was ¥87,784,300.11, up 23.54% from ¥71,060,167.59 year-on-year[8] - Basic earnings per share increased to ¥0.35, reflecting a 25.00% growth from ¥0.28 in the same quarter last year[8] - The weighted average return on equity was 3.90%, up from 3.52% in the previous year[8] - The company expects net profit attributable to shareholders for the first half of 2018 to be between CNY 142.81 million and CNY 185.66 million, representing a growth of 0% to 30% compared to the same period in 2017[22] Cash Flow and Assets - The net cash flow from operating activities was -¥534,629,181.86, a decline of 162.18% compared to -¥203,917,520.51 in the previous year[8] - Total assets at the end of the reporting period were ¥10,041,611,477.17, a 9.09% increase from ¥9,204,580,842.02 at the end of the previous year[8] - Net assets attributable to shareholders rose to ¥2,294,991,607.61, marking a 3.98% increase from ¥2,207,207,307.50[8] - Prepayments at the end of the reporting period increased by CNY 58.68 million, a growth of 32.04%, mainly due to payments made to suppliers for goods not yet received[16] - Other non-current assets decreased by CNY 0.46 million, a reduction of 37.13%, primarily due to the arrival of equipment for which payments had been made[16] - Employee compensation payable decreased by CNY 13.95 million, a decrease of 65.57%, mainly due to the payment of year-end bonuses[16] - Tax payable decreased by CNY 34.92 million, a reduction of 35.85%, primarily due to tax payments made during the reporting period[16] - Financial expenses increased by CNY 20.38 million, a growth of 114.17%, mainly due to increased financing amounts and rising financing costs[16] - Net cash flow from operating activities decreased by CNY 330.71 million, a decrease of 162.18%, primarily due to increased cash payments to suppliers[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,733[12] - The largest shareholder, China Youth Industrial Development Corporation, held 16.72% of the shares, totaling 41,876,431 shares[12] Acquisitions - The company acquired 51% of Zhejiang Tonghuan Biotechnology Co., Ltd. for CNY 43.76 million, with an outstanding payment of CNY 39.38 million as of the report date[18] - The company acquired 51% of Zhejiang Jiashang Medical Technology Co., Ltd. for CNY 61.20 million, with an outstanding payment of CNY 55.08 million as of the report date[19] - The company acquired 51% of Chengdu Rongjin Pharmaceutical Trade Co., Ltd. for CNY 99.45 million, with an outstanding payment of CNY 44.13 million as of the report date[19]